Market News
Analysts Expect PDP Will Reach $101
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding ...
Is Advanced Micro Devices (AMD) a Buy?
Chipmaker Advanced Micro Devices (NASDAQ: AMD) doesn’t have the market share or Wall Street buzz that archrival Nvidia does in the artificial intelligence (AI) ...
NCL Stock Earnings: Northann Reported Results for Q4 2023
Source: iQoncept / Shutterstock Northann (NYSEMKT:NCL) just reported results for the fourth quarter of 2023. Northann reported earnings per share of -18 cents. The ...
Chart of the Day: Pilgrim's Pride – Healthy Meat Alternative
The Chart of the Day belongs to the major chicken processor Pligrim’s Pride (PPC) . I found the stock by using Barchart’s powerful screening ...
1 Mining Stock Set to Benefit from Russian Metals Sanctions
Mining stocks are cyclical, and their performance is tied to the prices of the commodities they mine. In the last two years, inflation and ...
Tesla Below $150: What Comes Next, According to Canaccord
Tesla (NASDAQ:TSLA) is going through a tough patch. On the back of ongoing share losses (40% year-to-date), the stock has hit 52-week lows, with ...
3 Energy Stocks to Sell Before Oil Prices Stall
Source: Golden Dayz / Shutterstock.com Is the rally crude oil about to stall out? After several months of consistent oil price advances, the price ...
This Stock Has A 5.00% Yield And Sells For Less Than Book
FinVolution Group (Symbol: FINV) has been named as a Top 25 dividend stock, according the most recent Dividend Channel ”DividendRank” report. The report noted ...
7 Growth Stocks to Buy Now: Q2 Edition
InvestorPlace – Stock Market News, Stock Advice & trading Tips Investing in growth stocks can deliver outsized gains, but investors have to stick with ...
Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
Source: Numstocker/Shutterstock.com Hepion Pharmaceuticals (NASDAQ:HEPA) stock is diving on Monday after the biopharmaceutical company announced plans to wind down a clinical trial. A press release ...
